ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 26 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $44,000 | -27.9% | 228,215 | -11.9% | 0.00% | – |
| Q1 2022 | $61,000 | -60.9% | 258,920 | -2.0% | 0.00% | – |
| Q4 2021 | $156,000 | -32.2% | 264,239 | +3.5% | 0.00% | – |
| Q3 2021 | $230,000 | -29.2% | 255,420 | +2.3% | 0.00% | – |
| Q2 2021 | $325,000 | +23.1% | 249,606 | +31.5% | 0.00% | – |
| Q1 2021 | $264,000 | +25.7% | 189,802 | +15.7% | 0.00% | – |
| Q4 2020 | $210,000 | +5.0% | 164,056 | +21.3% | 0.00% | – |
| Q3 2020 | $200,000 | -5.2% | 135,198 | +1.2% | 0.00% | – |
| Q2 2020 | $211,000 | +81.9% | 133,542 | +10.8% | 0.00% | – |
| Q1 2020 | $116,000 | -66.9% | 120,556 | -6.0% | 0.00% | – |
| Q4 2019 | $350,000 | -42.2% | 128,254 | -16.7% | 0.00% | – |
| Q3 2019 | $606,000 | +28.7% | 154,016 | +33.2% | 0.00% | – |
| Q2 2019 | $471,000 | -89.0% | 115,656 | -81.0% | 0.00% | – |
| Q1 2019 | $4,268,000 | +34.6% | 607,893 | +4.5% | 0.00% | – |
| Q4 2018 | $3,172,000 | -48.8% | 581,971 | +0.8% | 0.00% | – |
| Q3 2018 | $6,201,000 | -16.2% | 577,443 | +1.7% | 0.00% | – |
| Q2 2018 | $7,397,000 | +189.7% | 567,707 | +145.1% | 0.00% | – |
| Q1 2018 | $2,553,000 | +11.9% | 231,654 | +2.2% | 0.00% | – |
| Q4 2017 | $2,281,000 | – | 226,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
| AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
| Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
| Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
| Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
| Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
| PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |